Evidence mapPaperPMID 42110487Full record

ArticleJournal of registry management2025

Trends in Early-Onset and Late-Onset Colorectal Cancer by Subtype in New York State, 1976-2022.

Rakkoo Chung, Margaret Gates Kuliszewski, Tabassum Insaf

Abstract read
In one paragraph

Article in Journal of registry management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rakkoo ChungNew York State Cancer Registry, New York State Department of Health, Albany, NY.
Margaret Gates KuliszewskiNew York State Cancer Registry, New York State Department of Health, Albany, NY.
Tabassum InsafNew York State Cancer Registry, New York State Department of Health, Albany, NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite the steadily decreasing incidence rate of colorectal cancer (CRC) overall, many studies have reported increasing incidence of CRC among younger people (age < 50), early-onset colorectal cancer (EOCRC), in the United States. However, fewer studies have examined the trends by CRC subtype. We sought to better understand the trends of CRC incidence by subtype and age at diagnosis (particularly before age 50 versus age 50 or later) in recent decades in New York State and in other areas in the United States. Methods: Using the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) data, we estimated incidence rates of CRC for 11 subtypes, for different age groups, and by stage (local versus regional and distant) from 1976 through 2022 in New York State, compared with the same estimates from 2000 through 2021 in all 22 United States SEER cancer registries. All incidence rates are per 100,000 and age-adjusted to the 2000 United States standard population. Results: While the overall incidence rate of all CRC combined decreased for ages 50 and above from 229.5 in 1976-1980 to 106.3 in 2021-2022, it increased for ages under 50 from 5.9 to 10.0 during the same period. For ages under 50, the subtype-specific incidence rates increased for appendix (from 0.04 to 1.3), rectum (from 1.3 to 3.1), and sigmoid colon (from 1.2 to 2.1), while the other subtypes showed relatively low and steady incidence rates. For ages 50 and above, most subtypes showed generally decreasing incidence rates, with the exception of appendix, which steadily increased from 0.3 to 3.8. Data from the 22 registries combined showed almost identical trends. Conclusion: While aggregate statistics show increasing incidence rates of EOCRC, it is important to consider trends by CRC subtype. We observed that the increasing trends of EOCRC are primarily driven by appendix, rectum, and sigmoid colon cancers, and that the incidence rate of appendix cancer has been increasing across all age groups. Future studies should consider differences by subtype of CRC, as this information may help elucidate factors contributing to recent trends in EOCRC incidence.

Indexed as

Colorectal NeoplasmsAdultAgedAge DistributionAge of OnsetFemaleHumansIncidenceMaleMiddle AgedNew YorkSEER ProgramUnited StatesColorectal cancerearly-onset colorectal cancerIncidenceSurveillance, Epidemiology, and End Results (SEER) Program

Identifiers

PMID42110487
PMCPMC13151759

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.